{
  "domain": "xoma.com",
  "punycode": "xoma.com",
  "tld": "com",
  "cc_first_seen": "2013-05-22T16:11:10Z",
  "cc_last_seen": "2026-06-14T06:51:24Z",
  "cc_capture_count": 568,
  "last_status": 406,
  "https": true,
  "title": "Investor Relations :: XOMA Royalty Corporation (XOMA)",
  "meta_description": "XOMA Royalty has built a significant portfolio of products that are licensed to and being developed by other biotechnology and pharmaceutical companies.&nbsp; The Company’s portfolio of partner-funded programs spans multiple stages of the&#8230;",
  "detected_cms": "wordpress",
  "server": "Apache",
  "language": null,
  "sources": [
    {
      "name": "commoncrawl-columnar",
      "detail": "CC-MAIN-2013-20..CC-MAIN-2026-25, homepage captures",
      "retrieved_at": "2026-07-05T05:13:18.522Z"
    },
    {
      "name": "commoncrawl-warc",
      "detail": "crawl-data/CC-MAIN-2026-25",
      "retrieved_at": "2026-07-05T05:13:18.522Z"
    }
  ],
  "schema_version": 1,
  "updated_at": "2026-07-05T05:13:18.522Z"
}
